David Shaw’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.09M Buy
353,157
+187,816
+114% +$4.35M ﹤0.01% 1899
2026
Q1
$3.4M Buy
165,341
+125,056
+310% +$2.82M ﹤0.01% 2480
2025
Q4
$955K Buy
40,285
+18,612
+86% +$453K ﹤0.01% 3573
2025
Q3
$540K Buy
+21,673
New +$466K ﹤0.01% 3828
2023
Q1
Sell
-391,456
Closed -$8.89M 4774
2022
Q4
$8.89M Sell
391,456
-78,254
-17% -$2.18M 0.01% 1548
2022
Q3
$16M Buy
+469,710
New +$17.4M 0.02% 1000

Other funds holding PRVA

David Shaw's PRVA Position: Q2 2026 in Review

David Shaw increased its Privia Health (PRVA) stake by 114% in Q2 2026, buying an estimated $4.35M and bringing the position to 353,157 shares worth $9.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

David Shaw first reported a position in PRVA in Q3 2022 and has held it in 6 quarters since. The position peaked at $16M in Q3 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • David Shaw held 353,157 shares of Privia Health worth $9.09M as of Q2 2026.
  • David Shaw bought 187,816 Privia Health shares in Q2 2026, an estimated $4.35M.
  • Privia Health made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1899 holding.
  • David Shaw first reported a position in Privia Health in Q3 2022 and has held it in 6 quarters since.
  • David Shaw's Privia Health position peaked at $16M in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.